Drug Approval | May 04, 2022
Alkem launches Innohaler for asthma & COPD patients
With the introduction of this device, Alkem is entering the core inhalation therapeutics and envisaging that the drug will reach the lungs effectively in each inhalation with added patient awareness and adherence programmes
